Insider Buying Stocks
WGS is part of our Insider Buying Stocks list, indicating stock insiders are buying the stock.
GENEDX HOLDINGS CORP (WGS) Stock Price & Overview
NASDAQ:WGS • US81663L2007
Current stock price
66.86 USD
+5.88 (+9.64%)
At close:
66.95 USD
+0.09 (+0.13%)
Pre-Market:
The current stock price of WGS is 66.86 USD. Today WGS is up by 9.64%. In the past month the price decreased by -12.15%. In the past year, price decreased by -29.97%.
WGS Key Statistics
52-Week Range55.17 - 170.87
Current WGS stock price positioned within its 52-week range.
1-Month Range55.18 - 77.785
Current WGS stock price positioned within its 1-month range.
- Market Cap
- 1.958B
- P/E
- 47.76
- Fwd P/E
- 94.57
- EPS (TTM)
- 1.40
- Dividend Yield
- N/A
WGS Stock Performance
Today
+9.64%
1 Week
-0.04%
1 Month
-12.15%
3 Months
-38.14%
Longer-term
6 Months -44.72%
1 Year -29.97%
2 Years +291.68%
3 Years +640.52%
5 Years N/A
10 Years N/A
WGS Stock Chart
WGS Stock Screens
WGS currently appears in the following ChartMill screener lists.
WGS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to WGS. When comparing the yearly performance of all stocks, WGS is a bad performer in the overall market: 91.23% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
WGS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to WGS. While WGS seems to be doing ok healthwise, there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
WGS Earnings
On February 23, 2026 WGS reported an EPS of 0.14 and a revenue of 120.99M. The company beat EPS expectations (24.4% surprise) and missed revenue expectations (-0.51% surprise).
Next Earnings DateApr 28, 2026
Last Earnings DateFeb 23, 2026
PeriodQ4 / 2025
EPS Reported$0.14
Revenue Reported120.989M
EPS Surprise 24.40%
Revenue Surprise -0.51%
WGS Forecast & Estimates
13 analysts have analysed WGS and the average price target is 159.8 USD. This implies a price increase of 139.01% is expected in the next year compared to the current price of 66.86.
For the next year, analysts expect an EPS growth of -49.5% and a revenue growth 28.89% for WGS
Analysts
Analysts84.62
Price Target159.8 (139.01%)
EPS Next Y-49.5%
Revenue Next Year28.89%
WGS Groups
Sector & Classification
WGS Financial Highlights
Over the last trailing twelve months WGS reported a non-GAAP Earnings per Share(EPS) of 1.4. The EPS increased by 508.7% compared to the year before.
Income Statements
Revenue(TTM)427.54M
Net Income(TTM)-21.02M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.01% | ||
| ROE | -6.82% | ||
| Debt/Equity | 0.21 |
Chartmill High Growth Momentum
EPS Q2Q%-77.42%
Sales Q2Q%26.5%
EPS 1Y (TTM)508.7%
Revenue 1Y (TTM)39.97%
WGS Ownership
Ownership
Inst Owners106.57%
Shares29.29M
Float25.58M
Ins Owners1.86%
Short Float %15.42%
Short Ratio5.09
WGS Competitors/Peers
The largest stocks on the US markets in the "Health Care Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.72 | 99.478B | ||
| CI | THE CIGNA GROUP | 8.72 | 71.874B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 96.78 | 29.577B | ||
| LH | LABCORP HOLDINGS INC | 14.6 | 22.155B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.22 | 21.332B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.333B | ||
| DVA | DAVITA INC | 10.58 | 9.983B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 28.98 | 8.857B | ||
| CHE | CHEMED CORP | 15.61 | 5.183B | ||
| HIMS | HIMS & HERS HEALTH INC | 36.74 | 4.869B | ||
| RDNT | RADNET INC | 88.28 | 4.483B | ||
| OPCH | OPTION CARE HEALTH INC | 14.68 | 4.365B | ||
| BLLN | BILLIONTOONE INC CL A | 169.96 | 3.806B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About WGS
Company Profile
GeneDx Holdings Corp. operates as a health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,300 full-time employees. The company went IPO on 2020-09-04. The firm operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. The company operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. The company offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Company Info
IPO: 2020-09-04
GENEDX HOLDINGS CORP
333 Ludlow Street, North Tower, 6Th Floor
Stamford CONNECTICUT US
Employees: 1300
Phone: 18009279800
GENEDX HOLDINGS CORP / WGS FAQ
Can you describe the business of GENEDX HOLDINGS CORP?
GeneDx Holdings Corp. operates as a health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,300 full-time employees. The company went IPO on 2020-09-04. The firm operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. The company operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. The company offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
What is the current price of WGS stock?
The current stock price of WGS is 66.86 USD. The price increased by 9.64% in the last trading session.
Does GENEDX HOLDINGS CORP pay dividends?
WGS does not pay a dividend.
What is the ChartMill technical and fundamental rating of WGS stock?
WGS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Would investing in GENEDX HOLDINGS CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on WGS.
Can you provide the market cap for GENEDX HOLDINGS CORP?
GENEDX HOLDINGS CORP (WGS) has a market capitalization of 1.96B USD. This makes WGS a Small Cap stock.
Can you provide the ownership details for WGS stock?
You can find the ownership structure of GENEDX HOLDINGS CORP (WGS) on the Ownership tab.